BSE filing, NSE: AUROPHARMA. Summary written from the filing by ALFA Finder's alert engine.
Aurobindo Pharma Ltd: key numbers
- Share price
- ₹1,644.80
- Market cap
- ₹95,530 Cr
- Revenue (annual)
- ₹33,653 Cr
- Net profit (annual)
- ₹3,505 Cr
- P/E (TTM)
- 24.2×Sector 46.1×
- Promoter holding
- 51.88%+0.00% QoQ
- FII holding
- 17.41%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aurobindo Pharma Ltd
All →Aurobindo Pharma Board Meeting Date
Aurobindo Pharma's board meets 4 November 2026 to consider Q2 and half-year results and a possible interim dividend. Trading window stays closed until 6 November.
Aurobindo Pharma Other Announcement
Aurobindo Pharma Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as mandated by SEBI regulations.
Aurobindo Pharma Business Update
Aurobindo Pharma received USFDA final approval for Perampanel Tablets in multiple strengths. The product will be manufactured by its subsidiary and launched in Q3FY27.
Aurobindo Pharma Acquisition
Aurobindo Pharma's subsidiary, Apitoria Pharma, has completed the acquisition of the Contract Research Services business of A1 Biochem Group. The deal integrates CRO capabilities into Apitoria's operations.
Aurobindo Pharma Acquisition Worth ₹146.4 Cr
Aurobindo Pharma's subsidiary acquired 100% ownership of US-based A1 Biochem Labs LLC for USD 15.247 million in an all-cash deal.
- Value
- ₹146.4 Cr
Aurobindo Pharma Merger & Restructuring Worth ₹33.8 Cr
Aurobindo Pharma's subsidiary, Apitoria Pharma, completed a 20% stake dilution in A1 Biochem Labs. Dr. Rajendra Gadikota subscribed to securities worth ₹33.80 Crore.
- Value
- ₹33.80 Cr
Other production started announcements
All →EPack Prefab Technologies Production Started
EPACK Prefab commenced commercial production at its Ghiloth, Rajasthan facility effective October 28, 2026, adding 11,300 MT/annum of PEB capacity and 8,00,000 sq m/annum of PUF capacity. The project cost of around INR 100 Crore is not treated as an event value.
- PEB structures manufacturing capacity
- 11300.0 MT/annum
Zelio E-Mobility Production Started
Zelio E-Mobility began commercial production at its new Patan, Hisar plant on October 28, 2026. The plant adds 72,000 annual units of two- and three-wheeler capacity.
- manufacturing capacity (two- and three-wheelers)
- 72000.0 units per annum
Subros Production Started
Subros started commercial production at its new Kharkhoda greenfield plant on 28 October 2026. The plant adds 4.5 lakh units per annum of HVAC and hose capacity.
- HVAC and hose & tubes manufacturing capacity
- 4.5 lakh units per annum
ACME Solar Holdings Production Started
ACME Solar's subsidiary commissioned 35.77 MW/143.08 MWh of BESS capacity, bringing cumulative commissioned capacity to 195.35 MW/781.40 MWh. Commercial operation is scheduled for October 29, 2026.
- BESS discharge capacity commissioned
- 35.77 MW
Kalana Ispat Production Started
Kalana Ispat has commenced commercial production of alloy steel round bars at its new Khengaria rolling mill. The mill has an annual capacity of about 65,000 MT.
- alloy steel rolling mill capacity
- 0.065 MTPA
Jainik Power Cables Production Started
Jainik Power Cables commissioned a 400 kW solar plant at its Sonipat facility in October 2026. The installation supports energy efficiency and its ESR sustainability commitments.
- solar power plant capacity
- 400 kW